Tonix Pharmaceuticals, a clinical-stage biopharmaceutical company, announced that it will effect a 1-for-32 reverse stock split of its outstanding …
Read more on pharmprom.net
Pharmaceutical Industry in Russia flipped this story into PharmProm.Net•50d
